Chalcones play an important role in living organisms with a wide range of biological activities including potent antitumor activity. Previously, we reported that N-aryl piperazine compounds have excellent biological activity. To further explore the structure–activity relationships, a series of novel hybrid compounds between chalcone and piperazine have been synthesized, and their in vitro antitumor activity was evaluated against a panel of human tumor cell lines. The results demonstrated that compounds bearing acetophenone showed better anticancer activity than cisplatin and other hybrid compounds, and that substitution of the acetophenone with halogen atom, was vital for modulating cytotoxic activity. Among all synthetic derivatives, hybrid compound 7c was found to be the most potent compound against A549, Hela and SGC7901 (IC50 = 5.24 μM, 0.19 μM and 0.41 μM, respectively), importantly, 7c exerted obvious inhibitory effect in vivo.
18 November 2021 in International Immunopharmacology
A series of novel hybrid compounds between benzofuran and N-aryl piperazine have been synthesized and screened in vitro for anti-inflammatory activity in lipopolysaccharide (LPS)-stimulated RAW-264.7 macrophages and for anticancer activity against three human tumor cell lines. The results demonstrated that derivative 16 not only had inhibitory effect on the generation of NO (IC50 = 5.28 μM), but also showed satisfactory and selective cytotoxic activity against human lung cancer line (A549) and gastric cancer cell (SGC7901) (IC50 = 0.12 μM and 2.75 μM, respectively), which was identified as the most potent anti-inflammatory and anti-tumor agent in this study.